BamSEC and AlphaSense Join Forces
Learn More

Turn Therapeutics Inc. – Credit Agreements

NASDAQ: TTRX    
Share price (7/2/26): $7.12    
Market cap (7/2/26): $212 million

Credit Agreements Filter

EX-10.2
from 8-K 20 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Supplement to the Loan and Security Agreement Dated as of March 23, 2026 Among Turn Therapeutics Inc., a Delaware Corporation, (“Turn Therapeutics”), Turn Consumer LLC, a Delaware Limited Liability Company (“Turn Consumer”; and Together With Turn Therapeutics, Jointly and Severally, Individually and Collectively, “Borrower”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership, as Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and as a Lender
12/34/56
EX-10.1
from 8-K 33 pages Loan and Security Agreement Dated as of March 23, 2026 Among Turn Therapeutics Inc., a Delaware Corporation, (“Turn Therapeutics”), Turn Consumer LLC, a Delaware Limited Liability Company (“Turn Consumer”; and Together With Turn Therapeutics, Jointly and Severally, Individually and Collectively, “Borrower”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership, as Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and as a Lender (In Such Capacity, Together With Each Other Lender From Time to Time Party Hereto, a “Lender” and Collectively, the “Lenders”) Loan and Security Agreement
12/34/56